AS
ARTL icon

Altshuler Shaham’s Artelo Biosciences ARTL Stock Holding History

Altshuler Shaham’s Portfolio ARTL Stock Details ARTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$484K Buy
+889
New +$4.21K 0.01% 154

Other funds holding ARTL

KCM
Kathmere Capital Management Wayne, Pennsylvania $1.89B AUM 26.04% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $2.68B AUM 34.39% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Altshuler Shaham's ARTL Position: Q1 2026 in Review

Altshuler Shaham opened a new position in Artelo Biosciences (ARTL) in Q1 2026: 889 shares worth $484K. The stake represents 0.01% of the portfolio and ranks #154 among its holdings.

11 funds tracked by Wall St. Rank hold ARTL as of Q1 2026.

  • Altshuler Shaham held 889 shares of Artelo Biosciences worth $484K as of Q1 2026.
  • Artelo Biosciences was a new Altshuler Shaham position in Q1 2026.
  • Artelo Biosciences made up 0.01% of Altshuler Shaham's portfolio in Q1 2026, its #154 holding.
  • 11 funds tracked by Wall St. Rank held Artelo Biosciences as of Q1 2026.

Based on Altshuler Shaham's 13F filing for Q1 2026, filed 18 May 2026.